₹57,986 Cr
46.80
₹1,239 Cr
As on 13-Aug-2024 IST
₹329.20
•
1.22%
₹26,980.65
₹27,050.00
₹27,444.20
₹26,918.85
17,460
₹22,000.00 - 29,638.95
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Abbott India
| 19.51 | -0.59 | 3.56 | 15.07 | 13.67 | 24.72 | 29.33 |
|
BSE Healthcare
| 30.05 | 6.86 | 18.26 | 46.79 | 16.31 | 26.45 | 12.81 |
|
BSE Mid Cap
| 26.89 | -1.61 | 13.94 | 53.62 | 26.75 | 27.88 | 17.84 |
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|
|---|---|---|---|---|---|---|---|
|
Abbott India
| 6.95 | 9.66 | 23.75 | 20.01 | 72.50 | 36.72 | 17.00 |
|
BSE Mid Cap
| 45.53 | 1.38 | 39.18 | 19.87 | -3.05 | -13.31 | 48.13 |
|
BSE Healthcare
| 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 | 0.49 |
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Abbott India Ltd stood at ₹ 240 Cr as on 30-Nov-01
The share price of Abbott India Ltd is ₹27,309.85 (NSE) and ₹27,288.35 (BSE) as of 13-Aug-2024 IST. Abbott India Ltd has given a return of 13.67% in the last 3 years.
Abbott India Ltd has a market capitalisation of ₹ 57,986 Cr as on 13-Aug-2024. As per Value Research classification, it is a Mid Cap company.
Since, TTM earnings of Abbott India Ltd is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Abbott India Ltd and enter the required number of quantities and click on buy to purchase the shares of Abbott India Ltd.
Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolic, central nervous system, and vaccines, as well as multispecialty products for insomnia, vitamin D, pre-term labor, and pain management; and anti-infectives, cardio-diabetic, hormones, respiratory, hepatic, consumer care, gastro. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Capital India Limited.
The prominent promoters of Abbott India Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
ABBOTT CAPITAL INDIA LIMITED |
50.44%
|
|
ABBOTT HEALTHCARE PRODUCTS LIMITED |
17.62%
|
|
BRITISH COLLOIDS LTD |
6.92%
|
The chairman of the company is Munir Shaikh, and the managing director is Swati Dalal.
There is no promoter pledging in Abbott India Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
48,762
|
|
|
40,418
|
|
|
37,484
|
|
|
34,612
|
| Abbott India Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
--
|
|
Operating margin(%)
|
12.9
|
|
Net Margin(%)
|
13.18
|
|
Dividend yield(%)
|
--
|
Yes, TTM profit after tax of Abbott India Ltd was ₹1,239 Cr.
₹57,985.84 Cr
₹5,927.52 Cr
₹1,238.99 Cr
₹2,134.49 Cr
₹0.00 Cr
74.99%
High
₹22,000.00 - 29,638.95
₹10.00
2,12,49,302
BSE: 500488, NSE: ABBOTINDIA
Mumbai, Maharashtra
www.abbott.co.in
Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolic, central nervous system, and vaccines, as well as multispecialty... products for insomnia, vitamin D, pre-term labor, and pain management; and anti-infectives, cardio-diabetic, hormones, respiratory, hepatic, consumer care, gastro. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Capital India Limited. Read more
Stocks 
Abbott India Ltd.
Widely used:
